Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20191
20202
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Novartis Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Amgen1
Beeline Medicines Corporation1
Bristol-Myers Squibb1
Eli Lilly and Company1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases10
Lupus Erythematosus, Systemic4
Immune System Diseases3
Sjogren's Syndrome3
Multiple Sclerosis, Relapsing-Remitting2
Arthritis1
Arthritis, Rheumatoid1
Connective Tissue Diseases1
Demyelinating Diseases1
Dry Eye Syndromes1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.